IP Library Granted Patent US 11,534,753
Granted Patent B2
US 11,534,753 · App. 16/352,234 · Granted Dec 27, 2022

Microfluidic kidney-on-chip

Inventors: Ville Kujala (Medford, MA); Hyoungshin Park (Newton, MA); Sonalee Barthakur (Boston, MA); Sauveur Jeanty (Boston, MA); Brian Zuckerman (Cambridge, MA); Josiah Sliz (Boston, MA); Tanvi Shroff (Cambridge, MA); Geraldine A Hamilton (Boston, MA); Kyung-Jin Jang (Boston, MA); Ananth Nookala (Boston, MA); Gang Luo (Boston, MA); Donald Mckenzie (Boston, MA)
Assignee: EMULATE, INC.
B01L3/5027C12M23/16C12Q1/6809G01N33/5023G01N33/5064G01N33/5091B01L2300/0819B01L2400/0487C12M25/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,534,753
App. No.
16/352,234
Granted
Dec 27, 2022
Kind
B2
Abstract

The present invention relates to microfluidic fluidic devices, methods and systems as microfluidic kidney on-chips, e.g. human Proximal Tubule-Chip.

Claims (26)

1. A method of culturing, comprising:

a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a second surface, said first surface comprising proximal tubule cells and said second surface comprising glomerular microvascular endothelial cells;

b) exposing said proximal tubule cells and said glomerular microvascular endothelial cells to media under continuous low shear flow; and

c) culturing said proximal tubule cells such that said proximal tubule cells express aqua porin 1 (AQP1) with at least two-fold greater relative gene expression as compared to the same proximal tubule cells cultured in a static culture.

2. The method of claim 1 , wherein said proximal tubule cells are human primary proximal tubular epithelial cells.

3. The method of claim 2 , wherein said membrane contains pores.

4. The method of claim 3 , wherein said human primary proximal tubular epithelial cells are attached to the top of said membrane and said glomerular microvascular endothelial cells are attached to the opposite side of the same membrane.

5. The method of claim 1 , wherein said first surface of said membrane is part of a first microfluidic channel and said second surface of said membrane is part of a second microfluidic channel.

6. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express tight junction protein ZO-1.

7. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express beta-catenin.

8. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express occludin.

9. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express Na/K-ATPase.

10. The method of claim 2 , wherein said human primary proximal tubular epithelial cells comprise cilia.

11. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express one or more uptake and efflux transporters.

12. The method of claim 2 , wherein said continuous flow of media is 30 μl/hr.

13. The method of claim 2 , wherein said continuous flow of media is 150 μl/hr.

14. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express aquaporin 1 (AQP1) with at least four-fold greater relative gene expression as compared to the same human primary proximal tubular epithelial cells cultured in a static culture.

15. The method of claim 2 , wherein said human primary proximal tubular epithelial cells express aquaporin 1 (AQP1) with at least ten-fold greater relative gene expression as compared to the same human primary proximal tubular epithelial cells cultured in a static culture.

16. A method of culturing, comprising:

a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a second surface, said first surface comprising human primary proximal tubular epithelial cells and said second surface comprising glomerular microvascular endothelial cells;

b) culturing said human primary proximal tubular epithelial cells and said glomerular microvascular endothelial cells to media under continuous low shear flow such that said human primary proximal tubular epithelial cells express beta-catenin; and

c) detecting said human primary proximal tubular epithelial cells expressing beta-catenin.

17. A method of culturing, comprising:

a) providing a microfluidic device comprising a membrane, said membrane comprising a first surface and a second surface, said first surface comprising human primary proximal tubular epithelial cells and said second surface comprising glomerular microvascular endothelial cells;

b) culturing said human primary proximal tubular epithelial cells and said glomerular microvascular endothelial cells to media under continuous low shear flow such that said human primary proximal tubular epithelial cells express occludin; and

c) detecting said human primary proximal tubular epithelial cells expressing occludin.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 28, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073365/0249 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2025
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: EMULATE, INC.
Reel/Frame 073116/0888 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2022
From: PARK, HYOUNGSHIN; JANG, KYUNG-JIN; SHROFF, TANVI; BARTHAKUR, SONALEE; ZUCKERMAN, BRIAN; KUJALA, VILLE; JEANTY, SAUVEUR
To: EMULATE, INC
Reel/Frame 061857/0650 →
SECURITY AGREEMENT Recorded Aug 25, 2021
From: EMULATE, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 057311/0564 →
Continuity (2)
Continuation In Part PCTUS2019019250 · Feb 22, 2019
Related Publication 20200269234A1 · Aug 27, 2020